Safety and Efficacy of VDPHL01 in Males and Females With AGA

Clinical trial NCT06527365 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06527365
Sponsor: Veradermics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Androgenetic Alopecia AGA Male Pattern Baldness

Start date: 2024-07-08
Primary completion: 2026-08-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.